The aim of this study was to evaluate the efficacy of different radioactive iodine (I-131)
activities used for re-ablation, to compare various combinations of treatment activities, and to …

Thyroid stunning is a radiobiological phenomenon. It may be defined as a temporary
suppression of iodine, trapping function of the thyrocytes and thyroid cancer cells as a result …

Objective To evaluate the relationships between thyroid remnant 131I uptake, radiation
thyroiditis and remnant ablation success rate between lower (1110áMBq) and higher …

Objective Postoperative radioiodine remnant ablation (RRA) represents an adjunctive
therapeutic modality in patients with differentiated thyroid cancer (DTC). The impact of late …

Version 3 of the procedure guideline for 131 I whole-body scintigraphy (WBS) is the
counterpart to the procedure guideline for radioiodine therapy (version 3) and specify the …

Objective To retrospectively evaluate the outcomes of patients with low and intermediate risk
thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine …

Context: The utility of preablation radioiodine scans for the management of differentiated
thyroid cancer remains controversial. Objective: To determine the contribution of preablation …

Background: No long-term follow-up data are available for differentiated thyroid carcinoma
(DTC) patients prepared with either exogenous or endogenous TSH and treated with low …

Objective (a) To compare the efficacy of low-activity (2 GBq; 54 mCi) 131I ablation using l-
thyroxine withdrawal or rhTSH stimulation, and (b) to assess the influence of thyroid …

Background: I-131 has been used in the therapy of well-differentiated thyroid cancer for over
50 years. Although the benefits and risks of I-131 remain issues of controversy and research …